Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1,850.00p 1,800.00p 1,900.00p 1,850.00p 1,850.00p 1,850.00p 293 06:30:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 5.5 4.2 69.2 26.7 94.33

Bioventix (BVXP) Latest News

More Bioventix News
Bioventix Takeover Rumours

Bioventix (BVXP) Share Charts

1 Year Bioventix Chart

1 Year Bioventix Chart

1 Month Bioventix Chart

1 Month Bioventix Chart

Intraday Bioventix Chart

Intraday Bioventix Chart

Bioventix (BVXP) Discussions and Chat

Bioventix Forums and Chat

Date Time Title Posts
10/7/201713:47Bioventix - Sheep Antibodies557
08/11/201613:07ShareSoc Supper in Brighton-

Add a New Thread

Bioventix (BVXP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:25:211,832.001041,905.28O
13:11:071,805.00590.25O
11:27:321,800.0024432.00O
11:08:261,805.00590.25O
09:32:571,900.0050950.00O
View all Bioventix trades in real-time

Bioventix (BVXP) Top Chat Posts

DateSubject
20/7/2017
09:20
Bioventix Daily Update: Bioventix is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker BVXP. The last closing price for Bioventix was 1,850p.
Bioventix has a 4 week average price of 1,755p and a 12 week average price of 1,750p.
The 1 year high share price is 2,025p while the 1 year low share price is currently 912.50p.
There are currently 5,098,656 shares in issue and the average daily traded volume is 1,467 shares. The market capitalisation of Bioventix is £94,325,136.
09/6/2017
09:36
a1samu: With the £ weak, resulting in more profits, for this company, this share price should be going up not down on account of the pound? In any event, this company is not threatened by any outside factors or are the Chinese commencing their unique tests and swamping the market with their cheap processes? This should be going up not down!
11/5/2017
14:15
valhamos: The share price increase at AIR I would suggest would have happened regardless of the share split in January and in fact it was increasing out of its range from August 2016 (when I made my last purchase and I still hold) as a result of a strongly positive trading update.
11/5/2017
13:21
carcosa: There is sufficient evidence to confirm that when a share price rises to the levels we are seeing with BVXP that a share-split does indeed attract new investors. It happens more frequently in America where the stock (shares in British parlance) price alone can be used as a rough and ready valuation tool against other stocks within the same sectors. Is it logical? Perhaps not. Personally I do not much like share-splits as it appears to result in more volatility which I dislike. Still, if investing was all about logic then we would not be having so much fun...
11/5/2017
11:47
referencepoint: Like the fact that it carries a high share price (think Berkshire Hathaway). More importantly is the very low number of shares in issue circa 5m. Any good news creates the usual demand for shares with very limited supply. Consequently this can create a disproportionate favourable price movement. (However, the opposite is also true following bad news) so you really need to bear this in mind when selecting companies to buy. Bioventix will outperform over time.
11/5/2017
11:34
panic investor: certainly brings in other punters (the ones that look at a share price and think its expensive) I've the same problem, if you can call it that with ASCO NMC etc
12/10/2016
13:49
ilovefrogs: Very much enjoyed the video, and the Payton blog. I've been a holder since April 2015, and have added a number of times when the stock was below £10 - avge in price about £9.20. Still decent risk/reward stock even with the recent move, but I think the staff retention point is a good one. I suspect that the firm will need to tie it's PHDs in more strongly, although an LTIP structured through share options would be the best approach IMV. Timing od Siemens Troponin test clearly going to be a near-term (1 yr) share price driver, but I do like the fact that they simply stop the old test one day, and start the new one the next, so this doesn't seem like a slow ratchet up of revenues, but a sudden jump. Definitely worth staying with this one, and lets see what the results on Monday tell us!!
22/8/2016
08:11
janeann: http://uk.advfn.com/stock-market/london/bioventix-BVXP/share-news/Bioventix-Plc-Trading-Update-and-Notice-of-Results/72258111
23/3/2016
21:58
johnsmith321: Hi Bamboo interesting observation. Alot of shares were sold today (£950,000). The share price decline is probably only short term. As the interim and outlook were very positive and stock is not over valued on P/E or div yield.
14/1/2016
16:12
stepone68: If you google cardinor there are several pieces saying it's a new startup which has received $750,000 funding. If Bioventix have just paid $75,000 for 10% of it (as johnsmith says above) then there's no reason why the share price should move. I don't know where johnsmith got his figures from though.
11/11/2015
16:34
stepone68: Depends what you are looking for. They say themselves 'modest growth' for the next couple of years. My guess is not much will happen to the share price over that time, but at least they pay a dividend !
Bioventix share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20170720 20:27:41